Zeolite marketing has a habit of gesturing at officialdom. You will see phrases like “FDA GRAS,” “recognized as safe,” and “EU registered” on product pages, usually without any explanation of what was actually recognized, by whom, and for what use. The real regulatory record is not hard to read, and it is more specific than the marketing. Here is what the documents say.
Key Takeaways
- There is no FDA approval for oral clinoptilolite in humans. Supplements do not get approved before sale, so no zeolite product has ever cleared that bar.
- The animal feed GRAS anticaking entries name specific aluminosilicate compounds capped at 2 percent of the ration [1]. Natural clinoptilolite is not one of the named entries.
- A GRAS notice for clinoptilolite of sedimentary origin was filed in 2017 and withdrawn in 2018 after FDA raised concerns about serum changes in animals and potential excess aluminum and iron [2].
- FDA has issued warning letters over zeolite disease claims, most recently in a 2023 letter citing detox, parasite, and wound-healing marketing [3].
- None of this makes zeolite dangerous. It means the burden of verification sits with you, not with an agency.
What “GRAS” Actually Covers
Generally Recognized As Safe is a legal category, not a seal of quality. It applies to a named substance, for a named use, at a named level. That specificity is the part that gets lost when it appears on a supplement page.
The relevant animal feed listings sit in Part 582, Subpart C, Anticaking Agents. Three entries come up in zeolite discussions: aluminum calcium silicate, sodium aluminosilicate, and hydrated sodium calcium aluminosilicate. Each is capped at 2 percent of the feed, in accordance with good manufacturing or feeding practice [1].
Read those three names again. They are aluminosilicate compounds, listed individually. Natural clinoptilolite, the sedimentary volcanic mineral in supplement capsules, is not among them. It is chemically an aluminosilicate, which is where the conflation comes from, but a GRAS listing attaches to the named substance and the named use, and “anticaking agent in animal feed at up to 2 percent” is a long way from “daily oral supplement for people.”
The GRAS Notice That Was Withdrawn
This is the part of the record most worth knowing, because someone did try to establish clinoptilolite GRAS status through the formal channel, and the attempt did not survive review.
In August 2017, G-Science, Inc. filed GRAS Notice AGRN 25 with FDA’s Center for Veterinary Medicine. The subject was clinoptilolite of sedimentary origin, and the proposed use was as an anticaking agent in diets for cattle, swine, goats, sheep, poultry, cats and dogs, at up to 2 percent by weight in complete diets [2].
FDA’s response letter, dated May 4, 2018, lists the issues raised during evaluation [2]:
- Published studies reporting conflicting evidence of changes induced by clinoptilolite in animal serum.
- A lack of publicly available information supporting the 2 percent level in dogs and cats.
- The possibility that 2 percent clinoptilolite by weight could cause excess levels of aluminum and iron for some species.
After teleconferences in January and April 2018, the notifier asked FDA to cease its evaluation, and FDA granted that request. The notice was withdrawn rather than denied, and the letter explicitly leaves the door open to a future resubmission. As of now, no such resubmission has produced a no-questions letter.
Two things follow. First, the only formal attempt to establish clinoptilolite GRAS status was for animal feed, not human consumption, and it did not complete. Second, the aluminum concern FDA raised is the same one that comes up repeatedly in supplement quality discussions, and it came from a regulator reading the submitted dossier rather than from a critic on the internet.
What Dietary Supplement Status Does and Does Not Mean
Under the U.S. dietary supplement framework, a product does not need premarket approval. The manufacturer is responsible for ensuring its product is safe and that its label claims are truthful and not misleading. FDA generally acts after a product is already on shelves.
That has a practical consequence for zeolite specifically. Because the mineral is mined, its composition varies by deposit. Natural zeolite beds can carry trace heavy metals, including the ones the product is being sold to remove. No agency is checking each lot before it ships. Third-party certificates of analysis exist precisely to fill that gap, which is why they are worth reading rather than skimming for a checkmark.
Where the Warning Letters Land
FDA enforcement against zeolite sellers has generally targeted claims rather than the mineral. The December 2023 warning letter to Ambaya Gold Health Products cites marketing language for a clinoptilolite product covering removal of heavy metals, chemicals and toxins, protection from worms, parasites and fungus, natural anti-inflammatory action, protection from infection, and accelerated wound recovery [3].
In regulatory terms, statements like those are disease claims, and a product making them is an unapproved new drug regardless of what the bottle calls itself. Memorial Sloan Kettering’s integrative medicine monograph makes the same point from the clinical side, noting that zeolite is marketed for a long list of conditions without published human data supporting those uses [4].
It is worth separating the enforcement question from the evidence question. A warning letter says a company made claims it was not entitled to make. It does not say the mineral does nothing. There is at least one controlled human study showing that purified clinoptilolite taken alongside a lead dose reduced enteral lead uptake in healthy volunteers [5]. That is a real, specific, gut-level finding. It is also a great deal narrower than “detoxes your body,” and the gap between those two statements is exactly what the warning letters are about.
The EU Picture Is Different, Not Stronger
Some purified clinoptilolite products in Europe are placed on the market under the medical device framework rather than as food supplements, on the reasoning that the mineral acts physically in the gut rather than pharmacologically. Clinoptilolite also has feed additive authorization in the EU.
Neither is equivalent to a drug approval. A device registration turns on demonstrating that a product performs as described and is safe for its stated purpose, under a route that does not require the clinical trial package a medicine would need. When a product page says “EU registered medical device,” the accurate reading is that it cleared a device pathway, not that a regulator concluded it treats anything.
How to Read a Zeolite Product Page After This
- Treat “FDA GRAS” as a prompt, not a credential. Ask which substance, which use, which level. If the answer is the animal feed anticaking listings, that is not a human supplement endorsement.
- Ignore “FDA registered facility.” Facility registration means the address is on a list. It carries no judgment about the product made there.
- Look for the certificate of analysis, per lot. Given deposit-to-deposit variation and FDA’s own aluminum and iron concern, contaminant testing is the single most informative document a seller can show you.
- Match the claim to the evidence level. Reduced enteral uptake of a metal taken at the same time is a supported, specific mechanism. Whole-body detoxification is not the same claim and does not carry the same support.
- Be more skeptical, not less, when the copy sounds official. The regulatory language on a page is often the least verified thing on it.
A Note on the Evidence
This article describes regulatory status, which is a separate question from whether a substance works. Nothing here is medical advice. Zeolite supplements are not approved by the FDA to diagnose, treat, cure, or prevent any disease. If you are considering zeolite because of a suspected exposure or a specific health problem, that is a conversation for a physician or a toxicologist, since genuine heavy metal poisoning has established medical treatments that a supplement does not replace.
Frequently Asked Questions
Is zeolite FDA-approved?
No. There is no FDA approval for oral clinoptilolite in humans for any medical use. Zeolite supplements are sold under the dietary supplement framework, which does not involve FDA reviewing or approving a product before it goes on sale. The manufacturer is responsible for the safety of what it sells and for the accuracy of its label.
Is zeolite GRAS?
Generally Recognized As Safe status is narrower than most marketing suggests. The anticaking agents listed in the animal feed GRAS regulations are specific aluminosilicate compounds, listed by name, capped at 2 percent of the ration. Natural clinoptilolite is not one of the named entries. A company did file a GRAS notice for clinoptilolite of sedimentary origin as an animal feed anticaking agent, and that notice was withdrawn before FDA finished evaluating it.
What happened with GRAS Notice AGRN 25?
G-Science filed it in August 2017 for clinoptilolite of sedimentary origin as an anticaking agent in livestock and pet diets at up to 2 percent by weight. During evaluation, FDA raised conflicting published evidence on clinoptilolite-induced changes in animal serum, a lack of public data supporting 2 percent in dogs and cats, and the possibility of excess aluminum and iron intake in some species. The notifier asked FDA to cease evaluation, and FDA granted that request on May 4, 2018.
Has FDA taken action against zeolite sellers?
Yes. FDA has issued warning letters to companies selling zeolite products with disease claims. A December 2023 letter to Ambaya Gold Health Products cited marketing language about removing heavy metals and toxins, protection from parasites and fungus, anti-inflammatory action, and accelerated wound recovery. Claims like those make a product an unapproved new drug in regulatory terms, regardless of what the label calls it.
Does the lack of approval mean zeolite is unsafe?
It means something narrower and more useful: no agency has reviewed a specific product and signed off on it. Absence of approval is not evidence of harm, and it is not evidence of benefit either. It shifts the burden onto the buyer to check third-party testing, contaminant results, and the actual evidence behind any given claim.
Is the situation different in the EU?
The pathways differ. Some purified clinoptilolite products in Europe are placed on the market under the medical device framework rather than as supplements, and clinoptilolite has feed additive authorization there. A device registration is a different thing from a drug approval, and it does not establish clinical efficacy for detox claims.
References
- 21 CFR 582.2727, Sodium aluminosilicate; see also 582.2122 Aluminum calcium silicate and 582.2729 Hydrated sodium calcium aluminosilicate, Subpart C Anticaking Agents. GovInfo
- Food and Drug Administration, Center for Veterinary Medicine. Response to GRAS Notice No. AGRN 25, clinoptilolite of sedimentary origin (May 4, 2018). FDA letter (PDF)
- Food and Drug Administration. Warning Letter to Ambaya Gold Health Products, LLC (December 5, 2023). FDA warning letter
- Memorial Sloan Kettering Cancer Center, Integrative Medicine. Zeolite monograph. MSKCC
- Concomitant oral intake of purified clinoptilolite tuff (G-PUR) reduces enteral lead uptake in healthy humans. Scientific Reports (2021). PMID 34285282
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
